Laboratorio Farmaceutico Erfo Spa announced Friday that the first exercise period for warrants to 2025 will open on June 12. Holders of the warrants will be entitled to subscribe for the compendium. | June 9, 2023
Laboratorio Farmaceutico Erfo Spa announced Thursday that its board of directors has approved the start of a buyback program for its own shares traded on Euronext Growth Milan. The purpose of the. | June 8, 2023
The board of directors of Laboratorio Farmaceutico Erfo Spa on Friday approved the consolidated financial statements as of December 31, 2022, reporting a net profit of EUR716,072, down 36 percent from. | March 31, 2023